Previous studies have shown that TRIM25 promotes the survival and growth of hepatocellular carcinoma cells through targeting the Keap1‒Nrf2 pathway [16]; Trim25 inhibits ITPKB degradation and imparts TMZ resistance in glioblastoma through ROS homeostasis [17]. This evidence concerns the gene TRIM25 and glioblastoma.